This content is machine translated Older patients with atopic dermatitis Why the Use of Biologics Is Recommended In light of demographic trends, an increase in the prevalence of atopic dermatitis is also being observed among the elderly population. Tailored treatment plans take into account a wide range...…
View Post 7 min This content is machine translated Plastic surgery and reconstructive microsurgery for DFS Functional limb preservation between infection control, vascular medicine and resurfacing Diabetic foot syndrome (DFS) is one of the most serious and functionally significant complications of diabetes, with a high number of functionally relevant amputations. DFS is not to be understood...… CME-Test
View Post 11 min This content is machine translated Peristomal skin health Focus on preventive care options For people with a stoma, peristomal skin health is a key factor for quality of life. With an incidence of up to over 70%, skin complications in the stoma area...… CME-Test
View Post 3 min This content is machine translated Tinea capitis: Current Guidelines and Recommendations What should be kept in mind when treating adult patients? Tinea capitis is less common in adults, but its incidence is on the rise. From a diagnostic perspective, one should be on the lookout for pathogens that are rather atypical...…
View Post 6 min This content is machine translated Head and neck squamous cell carcinoma Precision immunotherapy and local treatment The role of immunotherapy in the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC) is currently being reassessed. At the SOHC Congress 2025 in Basel, Yungan Tao...…
View Post 14 min This content is machine translated Seborrheic Dermatitis in Adults and Adolescents Current State of Knowledge and New Therapeutic Approaches Longitudinal multi-omics studies can help elucidate mechanisms and identify biomarkers that may predict disease recurrence or sustained remission. Conventional therapies are based primarily on antifungals, topical corticosteroids, and calcineurin inhibitors....… CME-Test
View Post 6 min This content is machine translated Psoriasis: therapy with biologics and TYK-2-i Progress assessments based on current long-term and real-world data A broad spectrum of systemic agents is now available for the treatment of moderate to severe psoriasis. At this year’s DDG congress “Dermatology compact + practical”, various studies were presented...…
View Post 0 min This content is machine translated Psoriasis in the Age of Precision Medicine Systemic Therapy for Patients with Comorbidities: What Is the Best Choice? ... Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post 5 min This content is machine translated Highlights from the AAD Annual Meeting Atopic Dermatitis: Interesting News on Drug Candidates in Phase III At the 2026 Annual Meeting of the American Academy of Dermatology (AAD), the latest study data on amlitelimab and rademikibart, among other topics, were presented during Late-Breaking Research sessions. The...…
View Post 8 min This content is machine translated When basal cell carcinomas prove difficult to treat Reaching the goal with innovative therapy strategies The further development of patient-oriented, function-preserving treatment strategies is an important concern of skin cancer research. For patients with advanced cutaneous basal cell carcinoma (BCC), there is a need for...…
View Post 3 min This content is machine translated Psoriasis Research: What's in the Pipeline? Highly selective oral TYK inhibitors in Phase III Envudeucitinib and Zasocitinib are oral, allosteric tyrosine kinase 2 (TYK2) inhibitors currently being evaluated in clinical trials for plaque psoriasis. The interim results presented during the Late-Breaking Research sessions at...…
